Docs, drugmakers conspire on lucrative new doses of old meds: NYT

Behind the usual pharma scenes is a network of doctors, small drugmakers and distributors hawking new dosages of old drugs, a practice that allows physicians to dispense them and reap the profits by billing insurers directly. States have tried to crack down on physician dispensing, but doctors and companies have found loopholes and devised new ways to stay ahead of the law, The New York Times reports. Story (sub. req.)